Tag: pharmaceuticals

  • FDA Approves Type 2 Diabetes Treatment

    The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, which when used with diet and exercise, can improve blood glucose control in adults with Type 2 diabetes. Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals in Ridgefield, Connecticut, and Eli Lilly Company in Indianapolis, Indiana. People with Type 2 diabetes do not produce or…

  • NIH Panel to Study Biomedical Workforce Future

    A National Institutes of Health (NIH) working group will study the U.S. biomedical workforce of the future, but with limited input from private companies. Of the 12 members of the panel, only one participant — Garry Neil, vice president of Johnson & Johnson in New Brunswick, New Jersey — is from the private sector. The…

  • Duke, Novartis to Develop Pandemic Virus Vaccines

    The Duke Human Vaccine Institute in Durham, North Carolina agreed today with the pharmaceutical company Novartis to collaborate on the rapid development of a vaccines in case of virus threats such as pandemic influenza. The agreement also creates a research partnership to tackle both basic and translational vaccine studies. The five-year agreement calls for the…

  • Manuka Honey Shows Potential For Drug-Resistant Wounds

    Research at University of Wales Institute, Cardiff suggests that manuka honey can help reverse bacterial resistance to antibiotics. Cardiff biologist Rose Cooper will report on her findings this week at a meeting of the Society for General Microbiology. Manuka honey is produced by bees fed on the flowers of the New Zealand manuka bush, and…

  • Drug Trial Reports Reduced Movements in Parkinson’s Patients

    A clinical trial of the investigational drug safinamide indicates the drug can reduce dyskinesia or involuntary movements in some patients with mid-to-late stage Parkinson’s disease. The findings will be presented at the annual meeting of the American Academy of Neurology in Honolulu, Hawaii. Study author Ravi Anand, with Newron Pharmaceuticals in Bresso, Italy, says the…

  • Field Test of New Clinical Trial Method Underway

    A field test has begun of a new type of clinical trial at the Veterans Affairs Boston (Mass.) Healthcare System, which proponents say is less costly and can also guide doctors to switch to the best treatment before the trial is completed. The new approach — called a point-of-care clinical trial — is described in…

  • African Plants Tested as Malaria Therapies, Insecticides

    Researchers at the Norwegian University of Life Sciences, near Oslo, are studying and testing plant extracts that have been used in traditional African medicine to fight malaria. The team hopes the project leads to supplements and replacements for today’s conventional medicines. Malaria is a mosquito-borne disease caused by a parasite. People with malaria often experience…

  • Antidepressants Aid in Long-Term Stroke Recovery

    A study at University of Iowa in Iowa City finds stroke victims can benefit from a brief treatment of antidepressants, with physical recovery continuing many months after the medication is stopped. The results of the study appeared in a recent issue of the American Journal of Geriatric Psychiatry (paid subscription required). A team led by…

  • FDA Approves Drug for Restless Legs Syndrome

    The U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). The drug was developed by Xenoport of Santa Clara, California and GlaxoSmithKline of Research Triangle Park, North Carolina. Horizant’s compound is gabapentin enacarbil that uses the body’s nutrient transport mechanisms that are believed to help…

  • FDA Adverse Drug Event Reports Jump in Past Decade

    Researchers at University of Maryland School of Pharmacy in Baltimore found a sharp increase in reports of adverse drug events to the Food and Drug Administration in the years 2000 through 2009, but the reasons for the jump may be more complex than the quality of the drugs. Their findings appear in the March issue…